Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...

Mounjaro (tirzepatide) is a brand-name injection prescribed for type 2 diabetes in adults. As with other drugs, Mounjaro can cause side effects, such as nausea, diarrhea, and appetite loss ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Gastroparesis is a chronic gastrointestinal (GI) condition affecting the nerves and muscles that help your stomach empty itself. When the stomach can’t move well, food sits inside, resulting in ...

Mounjaro (tirzepatide) is a prescription drug that may be prescribed off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight management. Mounjaro comes ...

A WOMAN has left TikTok users divided after claiming to have lost seven stone after taking weight loss drug Mounjaro for 11 months. Ashley says she's “happier than ever” thanks to the weight ...

Aims: Post-infectious gastroparesis (PIGP) is a subgroup of idiopathic gastroparesis. The aim of this study was to identify post-viral gastroparesis and to characterize clinical and ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...

Scott Disick faced those Mounjaro rumors head on when he admitted to using the weight loss drug. “It shows the Mounjaro? You’re lying!” Scott told Khloé, 40, when she called with the news.

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

The study used Mounjaro, which is not yet approved specifically for weight management. Over the last few years, there has been an increase in the use of glucagon-like peptide-1 receptor agonists ...